The lncOb rs10487505 polymorphism impairs insulin sensitivity and glucose tolerance in children and adolescents with obesity
Obesity · 2023-09 · 31 (9) · 2359-2364
DOI: 10.1002/oby.23835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, online erschienen am 07.08.2023. Verfasst von Giuseppina Rosaria Umano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of the Woman, the Child, and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy. Hauptthemen laut MEDLINE: Insulin Resistance, Pediatric Obesity, Prediabetic State. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Leptin plays a key role in the regulation of body weight and other endocrine systems. Recently, impairment of leptin gene transcription due to genetic variations in a long noncoding RNA ( lncOb ) has been described. This retrospective study aims to characterize the clinical and metabolic phenotype of children and adolescents with obesity who were homozygous for the lncOb rs10487505 leptin lowering allele.
Methods
Enrolled children underwent an anthropometrical evaluation, biochemical assessment, and genotyping for lncOb rs10487505. Plasma leptin levels were assessed in 150 participants. A total of 434 patients were included and divided into two groups according to rs10487505 recessive inheritance (CC vs. GG/GC).
Results
Children who were homozygous for the C allele showed higher fasting insulin ( p = 0.01), homeostasis model assessment of insulin resistance ( p = 0.01), lower whole‐body insulin sensitivity index ( p = 0.02), and lower disposition index ( p = 0.03). Moreover, CC patients presented with a higher prevalence of prediabetes (9.3% vs. 3.4%, p = 0.04) and a 2.9‐fold (95% CI: 1.1–7.9, p = 0.04) higher risk of prediabetes compared with G‐carriers independently from confounders. Leptin plasma levels were significantly lower in the CC group ( p = 0.002). Hormone levels correlated with BMI z score ( r = 0.19, p = 0.04), fasting insulin ( r = −0.34, p < 0.0001), homeostasis model assessment of insulin resistance ( r = −0.33, p < 0.0001), and disposition index ( r = 0.20, p = 0.04).
Conclusions
The lncOb rs10487505 polymorphism affects leptin circulating levels, worsens insulin resistance, and heightens the risk of prediabetes in children and adolescents with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of the Woman, the Child, and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.
- Department of Medicine and Health Sciences, "V. Tiberio" University of Molise, Campobasso, Italy.
- Department of Pediatrics, Kansas University Medical Center, Kansas City, Kansas, USA.
- Department of Pediatrics, School of Medicine, Yale University, New Haven, Connecticut, USA.
ORCID-Profile: Giuseppina Rosaria Umano
Zitieren
APA
Umano, G. R., Cirillo, G., Sanchez, G., Rondinelli, G., Foderini, M. V., Ferrara, S., Di Sessa, A., Marzuillo, P., Papparella, A., Santoro, N., & Miraglia Del Giudice, E. (2023). The lncOb rs10487505 polymorphism impairs insulin sensitivity and glucose tolerance in children and adolescents with obesity. Obesity, 31(9), 2359-2364. https://doi.org/10.1002/oby.23835
Vancouver
Umano GR, Cirillo G, Sanchez G, Rondinelli G, Foderini MV, Ferrara S, et al. The lncOb rs10487505 polymorphism impairs insulin sensitivity and glucose tolerance in children and adolescents with obesity. Obesity. 2023;31(9):2359-2364. doi:10.1002/oby.23835
BibTeX
@article{Umano2023,
author = {Umano, Giuseppina Rosaria and Cirillo, Grazia and Sanchez, Gianmaria and Rondinelli, Giulia and Foderini, Maria Vittoria and Ferrara, Serena and Di Sessa, Anna and Marzuillo, Pierluigi and Papparella, Alfonso and Santoro, Nicola and Miraglia Del Giudice, Emanuele},
title = {The lncOb rs10487505 polymorphism impairs insulin sensitivity and glucose tolerance in children and adolescents with obesity},
journal = {Obesity},
year = {2023},
volume = {31},
number = {9},
pages = {2359--2364},
doi = {10.1002/oby.23835}
}
EUVIMED